scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BCP.2008.08.020 |
P698 | PubMed publication ID | 18789902 |
P2093 | author name string | Klaus Brehm | |
Verena Gelmedin | |||
Rocio Caballero-Gamiz | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Echinococcus multilocularis | Q669922 |
P304 | page(s) | 1068-1081 | |
P577 | publication date | 2008-08-22 | |
P1433 | published in | Biochemical Pharmacology | Q864229 |
P1476 | title | Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors | |
P478 | volume | 76 |
Q28608107 | A Novel Terminal-Repeat Retrotransposon in Miniature (TRIM) Is Massively Expressed in Echinococcus multilocularis Stem Cells |
Q33972939 | Cestode genomics - progress and prospects for advancing basic and applied aspects of flatworm biology |
Q38093067 | Current drug targets for helminthic diseases |
Q30491719 | Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds. |
Q36291446 | EGF-mediated EGFR/ERK signaling pathway promotes germinative cell proliferation in Echinococcus multilocularis that contributes to larval growth and development |
Q37771996 | Echinococcosis with particular reference to Southeast Asia |
Q37599990 | Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes. |
Q37719252 | Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay |
Q51921125 | Echinococcus multilocularis as an experimental model in stem cell research and molecular host-parasite interaction. |
Q38697065 | Enzyme Activity Assays for Protein Kinases: Strategies to Identify Active Substrates |
Q41952623 | Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development. |
Q38974051 | Identification and characterization of functional Smad8 and Smad4 homologues from Echinococcus granulosus |
Q57800910 | Identification of functional MKK3/6 and MEK1/2homologs from and investigation of protoscolecidal activity of MAPK signaling pathway inhibitors and |
Q42630662 | Identification of putative insulin-like peptides and components of insulin signaling pathways in parasitic platyhelminths by the use of genome-wide screening. |
Q34529138 | In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis. |
Q48007887 | In vitro and in vivo efficacies of novel carbazole aminoalcohols in the treatment of cystic echinococcosis |
Q36869148 | In vitro effects of SB202190 on Echinococcus granulosus |
Q38627137 | In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes |
Q42272747 | In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis |
Q52723676 | Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of Echinococcus granulosus. |
Q37606590 | Molecular Cloning and Characterization of a P38-Like Mitogen-Activated Protein Kinase from Echinococcus granulosus. |
Q51888514 | Molecular characterisation of a serum-responsive, DAF-12-like nuclear hormone receptor of the fox-tapeworm Echinococcus multilocularis. |
Q42260166 | Molecular characterization of EmABP, an apolipoprotein A-I binding protein secreted by the Echinococcus multilocularis metacestode |
Q38294864 | On the importance of targeting parasite stem cells in anti-echinococcosis drug development. |
Q52574425 | Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets. |
Q26795698 | Recent advances in Echinococcus genomics and stem cell research |
Q34584194 | TGF-β and TGF-β/Smad signaling in the interactions between Echinococcus multilocularis and its hosts |
Q28539389 | Targeting Echinococcus multilocularis stem cells by inhibition of the Polo-like kinase EmPlk1 |
Q89869922 | The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis |
Q37727046 | The role of evolutionarily conserved signalling systems in Echinococcus multilocularis development and host-parasite interaction |
Q34741945 | Treatment of echinococcosis: albendazole and mebendazole--what else? |
Q27336465 | Using existing drugs as leads for broad spectrum anthelmintics targeting protein kinases |
Search more.